Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
October 14, 2022 07:30 ET
|
Enzo Biochem, Inc.
- Enzo Life Sciences reports revenue of $32.6 million and 8% growth in FY 2022, net of FX - Company successfully launched AMPIVIEW™ gene expression platform powered by LoopRNA™ ISH...
Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
October 10, 2022 11:31 ET
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for October 14, 2022, 8:30 am ET NEW YORK, NY, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
October 06, 2022 08:00 ET
|
Enzo Biochem, Inc.
100,000 square foot facility to support company plans for growth in clinical laboratory services, drug development services and product innovations Launch event to feature updates on Enzo plans for...
Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2
September 26, 2022 08:00 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW™...
Enzo Biochem to Launch Monkeypox Testing Services this Week
August 11, 2022 08:00 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that its full-service...
Enzo Biochem Appoints Matthew Kupferberg as General Counsel
August 03, 2022 08:00 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the addition of Matthew...
Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor
June 09, 2022 16:30 ET
|
Enzo Biochem, Inc.
Third quarter revenue of $26.2 million declined sequentially and year over year due to the anticipated waning of COVID-19 volumes and the economic shutdowns in Asia Received approval from New York...
UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
June 06, 2022 08:30 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, June 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2022 financial results...
Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
June 02, 2022 17:05 ET
|
Enzo Biochem, Inc.
Conference Call and Webcast Scheduled for June 9, 2022, 4:30 pm ET NEW YORK, NY, June 02, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
April 19, 2022 08:00 ET
|
Enzo Biochem, Inc.
NEW YORK, NY, April 19, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced that it has received approval from...